Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 26, 2021

CHMP recommends use of Pfizer-BioNTech’s Covid-19 vaccine in children

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the use of Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, in children aged five to 11 years.

Comirnaty will be administered in two doses at a gap of 21 days. Credit: Jan Felix Christiansen from Pixabay.